Skip to content
UPL logo

UPL

UPL NSE
₹571.95 +2.15 (+0.38%)
Market Cap
₹48,282 Cr
P/E
25.56
View as Markdown
MCP
Close 20 Nov 2026 ₹571.95 1Y −170.75 −23.0%
Start ₹742.70

Key Fundamentals

MidcapFertilizers & AgrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
10.10%
Debt to Equity
0.98
EPS (TTM)
₹22.38
Book Value
₹412.52
Market Cap
₹48,282 Cr
P/E (TTM)
25.56
P/B
1.39
ROE
5.64%
Dividend Yield
1.05%
EBITDA
₹9,935 Cr
52W High
₹812.20
52W Low
₹476.45
Day Range
₹563.65 – ₹576.75
Volume
20,08,386

Peer Comparison

Commodities › Fertilizers & Agrochemicals › Pesticides & Agrochemicals

UPL peer comparison
UPL (this company)
571.9525.5648,2821.391.09%5.64%10.10%52,6452,163
1,597.4027.6024,2352.120.92%11.20%15.00%6,345877
340.7030.4517,0064.610.39%17.60%23.50%3,168559
3,356.2020.2315,0834.742.69%23.70%29.10%5,293746
660.709.265,9611.832.15%23.20%30.20%5,479644
909.9014.404,0562.320.21%18.50%23.80%2,013283
186.9618.463,6361.661.58%10.20%14.10%2,959197
Median 7 companies660.7020.2315,0832.121.09%17.60%23.50%5,293644

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

51 Average

Data confidence 100/100

Category scores

Quality
55
Average
Returns, margins, earnings quality 22% weight
Valuation
80
Strong
Cheap vs sector & own history 24% weight
Growth
37
Poor
Sales & profit trajectory 9% weight
Financial Health
23
Poor
Solvency, leverage, coverage 9% weight
Momentum
28
Poor
Trend strength, vol-adjusted 12% weight
Ownership
47
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has been maintaining a healthy dividend payout of 24.4%

Weaknesses

3
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 6.02% over past five years.
  • Company has a low return on equity of 1.87% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish5410
OscillatorsBearish342
Moving AveragesStrong Bullish208

Key readings

RSI (14)
63.94
Neutral
MACD (12,26,9)
9.40
Bullish
SMA (50)
537.50
Bullish
SMA (200)
603.83
Bearish

As of

Analyst Rating

Based on 16 analysts
BUY75%

12 of 16 analysts rate Buy, 4 Hold, 0 Sell.

As of

BUY
12
75%
HOLD
4
25%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+13.95%
5Y+6.02%
3Y−1.09%
1Y+11.15%
TTM+10.33%

Net profit

Net profit growth by window
10Y+8.84%
5Y−8.68%
3Y−20.47%
1Y+170.73%
TTM−8.66%

Operating cash flow

Operating cash flow growth by window
10Y+18.86%
5Y+1.72%
3Y+0.45%
1Y−22.62%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+0.80 pp
5Y−4.07 pp
3Y−1.52 pp
1Y+2.23 pp
TTM+0.23 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹16,312 Cr
Mar 2018₹17,378 Cr
Mar 2019₹21,837 Cr
Mar 2020₹35,756 Cr
Mar 2021₹38,694 Cr
Mar 2022₹46,240 Cr
Mar 2023₹53,576 Cr
Mar 2024₹43,098 Cr
Mar 2025₹46,637 Cr
Mar 2026₹51,839 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1,733 Cr
Mar 2018₹2,030 Cr
Mar 2019₹1,575 Cr
Mar 2020₹2,178 Cr
Mar 2021₹3,495 Cr
Mar 2022₹4,437 Cr
Mar 2023₹4,414 Cr
Mar 2024−₹1,878 Cr
Mar 2025₹820 Cr
Mar 2026₹2,220 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹2,770 Cr +22.9% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 17 Nov 2026
AI opinion · based on fundamentals
Risk high

UPL Ltd trades at ₹551.7 as of 2026-11-17 with a market cap of ₹46,573 Cr, sitting 32% below its 52-week high of ₹812.2. The company shows a long-term sales CAGR of 14% over 10 years but has seen profit decline at -21% over 3 years, with ROE at 5.38% and debt-to-equity at 0.57, reflecting a business navigating margin and earnings headwinds despite a revenue base that has recently shown TTM sales growth of 10%.

Bull Case 6
  • 10-year compounded sales growth of 14% indicates a strong long-term revenue expansion track record for the agrochemical business
  • TTM sales growth has rebounded to 10%, suggesting a potential recovery in top-line momentum after a flat 3-year period of -1% sales CAGR
  • Debt-to-equity ratio of 0.57 is moderate and represents a manageable leverage position relative to the capital-intensive nature of the agrochemicals sector
  • The company has maintained a healthy dividend payout ratio of 24.4%, with a current dividend yield of 1.06%, providing some income to shareholders
  • 10-year compounded profit growth of 6% shows the company has been able to grow earnings over a longer cycle despite recent setbacks
  • Trading at ₹551.7 versus a 52-week low of ₹476.45, the stock has recovered roughly 16% from its bottom, indicating some stabilisation in investor sentiment
Bear Case 8
  • 3-year compounded profit growth of -21% signals a severe and sustained earnings decline, not a one-off event
  • 5-year compounded profit growth of -10% confirms that profitability erosion has persisted over a medium-term horizon
  • TTM profit growth of -19% shows earnings contraction is ongoing with no clear turnaround visible yet in the latest numbers
  • 3-year average ROE of just 2% (with last year at 6% and current ROE at 5.38%) indicates very poor capital efficiency relative to shareholder equity
  • The stock has delivered a 1-year return of -27% and a 5-year CAGR of -5%, substantially destroying shareholder value over both horizons
  • Low interest coverage ratio points to earnings being stretched thin relative to debt servicing obligations, raising financial risk
  • 5-year sales CAGR of only 6% is weak for a company in the commodities and agrochemicals space, where scale-driven growth is expected
  • PE TTM of 24.65 is elevated given the declining earnings trajectory — the market is pricing in a recovery that the recent profit trend does not yet support

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

22h ago

TL;DR: UPL is executing well operationally with eight straight quarters of EBITDA growth and strong performance in Specialty Chemicals, SUPERFORM, and Advanta seeds, but headline profits are pressured by higher finance costs and crop protection weakness. Key risks include elevated net debt, rising working capital days, and uncertainty around the corporate restructuring revision. The stock's 30% YTD decline reflects these overhangs, though improving credit ratings and retained FY27 guidance suggest the underlying trajectory is stabilizing — clarity on the restructuring plan will be the next major catalyst.

Headwinds 4
  • Q2 net profit drops 26% YoY Nov 02

    UPL reported Q2 net profit of ₹452 crore, down 26.14% from ₹612 crore a year ago, driven by higher finance costs and exceptional items. Crop protection volumes declined 16% due to drought in Europe and tight channel liquidity in LATAM.

  • Net debt rises to $3 billion Nov 02

    Total net debt stood at $3 billion as of September 2026, up $312 million YoY, with net working capital days rising from 118 to 145 days and inventory levels pushing DIO up by 16 days.

  • Restructuring plan faces revision Nov 17

    UPL is likely to revise its February 2026 corporate restructuring plan after brokerages flagged concerns over sizeable holding company discounts in the proposed two-entity split. No revised timeline or structure has been disclosed.

Positives 5
  • Eight quarters of EBITDA growth Nov 02

    UPL delivered its eighth consecutive quarter of EBITDA and margin growth, with Q2 EBITDA at ₹2,250 crore growing 2% YoY and operational PATMI rising 3% to ₹422 crore.

  • Specialty and seeds segments surge Nov 02

    Specialty Chemicals grew 50%, SUPERFORM revenue jumped 28% with EBITDA surging 73%, and Advanta seeds recorded 12% growth, demonstrating portfolio diversification strength.

  • Advanta acquires Egypt seed firm Nov 17

    UPL subsidiary Advanta plans to acquire a 99.98% stake in Egypt-based Misr Hytech Seed International for approximately $110 million, expanding its African agricultural seeds footprint with completion expected by January 31, 2027.

Neutral 2
  • New statutory auditors appointed Nov 02

    UPL appointed S R B C & Co LLP as statutory auditors for a 5-year term and made board-level and senior management appointments.

  • Superform targets continued growth Nov 03

    UPL's Superform specialty chemicals unit anticipates ongoing revenue and EBIT growth over the next two quarters, driven by higher volumes, new product launches, and contract manufacturing.

Quarterly Results

₹ Cr
UPL quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
10,170
9,887
14,078
9,067
11,090
10,907
15,573
9,216
12,019
12,269
18,335
10,181
11,860
Expenses
9,049
9,820
12,230
7,998
9,873
9,229
12,409
7,820
10,072
10,033
14,854
8,814
9,792
Operating Profit
1,121
67
1,848
1,069
1,217
1,678
3,164
1,396
1,947
2,236
3,481
1,367
2,068
OPM %
11%
0.7%
13%
12%
11%
15%
20%
15%
16%
18%
19%
13%
17%
Other Income
105
151
66
98
111
170
−168
152
250
92
178
208
186
Interest
871
1,191
1,090
913
1,070
730
914
1,007
784
774
836
852
819
Depreciation
657
676
794
660
697
688
705
731
771
827
915
832
819
Exceptional Items
−87
−17
—
−49
−8
−76
—
—
142
−56
−16
—
—
PBT
−389
−1,666
30
−455
−447
354
1,377
−190
784
671
1,892
−109
615
Tax %
−25%
−4%
367%
16%
31%
−141%
22%
−7%
22%
27%
32%
−33%
26%
Net Profit
−293
−1,607
−80
−527
−585
853
1,079
−176
612
490
1,294
−73
452
EPS (₹)
−2.42
−15.55
0.51
−4.91
−5.66
10.58
11.45
−1.12
6.56
4.70
12.57
0.12
4.99
YoY Sales growth
−19
−28
−15
1
9
10
11
2
8
12
18
10
−1

Profit & Loss

₹ Cr
UPL profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
12,091
14,048
16,312
17,378
21,837
35,756
38,694
46,240
53,576
43,098
46,637
51,839
52,645
Expenses
9,728
11,700
13,346
13,966
18,024
28,984
30,342
36,711
43,380
38,801
39,509
42,761
43,493
Operating Profit
2,363
2,348
2,966
3,412
3,813
6,772
8,352
9,529
10,196
4,297
7,128
9,078
9,152
OPM %
20%
17%
18%
20%
17%
19%
22%
21%
19%
10%
15%
18%
17%
Other Income
−11
149
363
351
−197
−515
62
91
464
483
78
663
591
Interest
517
704
735
783
963
1,481
2,060
2,295
2,963
3,852
3,627
3,401
3,281
Depreciation
425
676
672
675
880
2,012
2,173
2,359
2,547
2,763
2,750
3,244
3,393
Exceptional Items
—
—
—
—
—
—
—
—
—
−252
—
61
—
PBT
1,410
1,117
1,922
2,305
1,773
2,764
4,181
4,966
5,150
−2,087
829
3,157
3,069
Tax %
17%
15%
10%
12%
11%
21%
16%
11%
14%
−10%
1%
30%
—
Net Profit
1,187
952
1,733
2,030
1,575
2,178
3,495
4,437
4,414
−1,878
820
2,220
2,163
EPS (₹)
17.07
14.03
21.78
25.43
18.72
22.30
36.05
45.52
45.62
−15.34
11.46
22.78
22.38
Div. Payout %
19%
23%
20%
20%
27%
26%
27%
21%
21%
Not meaningful for this period: the ratio divides by a base close to zero, so it is left blank rather than shown as a very large number.
53%
26%
—
Sales growth
12
16
16
7
26
64
8
20
16
−20
8
11
10

Balance Sheet

₹ Cr
UPL balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
86
86
101
102
102
153
153
153
150
150
159
169
169
Reserves
5,775
5,803
7,214
9,067
14,613
19,129
20,734
24,508
26,708
24,657
29,054
34,527
34,655
Borrowings
3,281
5,258
6,443
6,638
29,139
29,388
24,519
26,746
23,939
29,754
25,099
23,576
34,240
Other Liabilities
5,143
5,722
6,454
7,148
18,581
19,758
23,359
29,196
35,318
30,579
31,700
34,847
31,958
Total Liabilities
14,284
16,869
20,212
22,955
62,435
68,428
68,765
80,603
86,115
85,140
86,012
93,119
1,01,022
Fixed Assets
4,031
3,862
4,071
4,437
32,149
35,321
34,765
36,193
38,713
39,056
39,084
42,153
43,949
CWIP
583
484
792
1,319
1,855
2,073
2,117
2,501
2,818
2,965
2,546
3,147
1,308
Investments
764
335
378
1,034
708
558
618
1,922
1,615
2,154
2,328
2,666
3,356
Other Assets
8,906
12,188
14,971
16,165
27,723
30,476
31,265
39,987
42,969
40,965
42,054
45,153
52,409
Total Assets
14,284
16,869
20,212
22,955
62,435
68,428
68,765
80,603
86,115
85,140
86,012
93,119
1,01,022

Cash Flow

₹ Cr
UPL cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1,409
1,396
2,585
2,839
2,356
8,739
7,212
6,496
7,751
2,321
10,151
7,855
Investing
−463
−1,734
−1,022
−2,059
−31,282
−2,666
−2,426
−3,575
−1,354
−2,509
−1,823
−1,475
Financing
−991
469
140
−801
28,893
−2,175
−6,713
−1,921
−6,227
164
−4,793
−9,883
Net Cash Flow
−45
131
1,703
−21
−33
3,898
−1,927
1,000
170
−24
3,535
−3,503
Free Cash Flow
878
703
1,382
1,435
803
6,804
5,147
3,931
5,462
367
8,896
5,502
CFO/EBITDA
71
78
99
90
71
141
95
79
88
81
156
93

Ratios

UPL financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
115
133
127
127
195
121
115
121
124
138
121
126
Inventory Days
178
204
194
204
306
153
180
216
187
198
155
179
Days Payable
195
213
228
255
330
199
244
274
236
196
164
169
Cash Conversion Cycle
98
124
93
76
171
75
51
64
76
141
113
135
Working Capital Days
45
48
84
94
127
59
52
36
46
52
9
5
ROCE %
21%
19%
22%
21%
10%
10%
13%
14%
14%
3%
8%
10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view UPL insights

68 extracted metrics across FY08–FY27.

Shareholding Pattern

As of Sep 2026

  • FIIs 43.67%
  • Promoters 33.51%
  • DIIs 14.31%
  • Public 6.50%
  • Others 2.00%
  • Government 0.01%

No promoter shares pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about UPL

What does UPL Ltd do?
UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.
Where is UPL Ltd (UPL) listed?
UPL Ltd trades as UPL on the NSE and under code 512070 on the BSE.
Which sector does UPL Ltd belong to?
UPL Ltd is classified under the Commodities sector, in the Fertilizers & Agrochemicals industry.
What is the market capitalisation of UPL Ltd?
UPL Ltd has a market capitalisation of ₹48,282 Cr as of 20 Nov 2026, which places it in the Midcap band.
What is the PE ratio of UPL Ltd?
UPL Ltd trades at a PE ratio of 25.56 as of 20 Nov 2026, on earnings per share of ₹22.38, against a book value of ₹412.52 per share.
What is the 52-week high and low of UPL Ltd?
Over the last 52 weeks UPL Ltd has traded between ₹476.45 and ₹812.2 as of 20 Nov 2026.
Does UPL Ltd pay dividends?
UPL Ltd has a dividend yield of 1.05%.
What is the Return on Equity (ROE) of UPL Ltd?
UPL Ltd reported a return on equity of 5.64%. Its debt-to-equity ratio is 0.98.

Company Information

UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.

Website upl-ltd.com
CEO Mr. Jaidev Rajnikant Shroff B.Sc.
Employees 12,000
Listed 23 Jan 2004
Face Value ₹2
Shares Outstanding 84,41,69,318

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/UPL.md for UPL Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More